M&A in the Pharmaceuticals sector in 2017. Prim acquires Anota for €1.23M.

14/12/2017
Diego Gutiérrez
M&A in the Pharmaceuticals sector in 2017. Prim acquires Anota for €1.23M.

We take a look at the main M&A transactions in the Spanish pharmaceutical sector in 2017. In addition, we analyse the purchase of Anota, specialised in distribution for pharmacies and orthopaedics, by Grupo Prim for €1.23M.

We take a look at the main M&A transactions in the Spanish pharmaceutical sector in 2017. In addition, we analyse the purchase of Anota, specialised in distribution for pharmacies and orthopaedics, by Grupo Prim for €1.23M.

About Anota

Anota is a company dedicated to the design, development, manufacture and distribution of technical aids and sports medicine products in the pharmacy and orthopaedic channel in the area of orthotics, podiatry, therapeutic compliance systems and technical aids.

Founded in 1990 with headquarters in Sabadell and offices in Barcelona and Madrid, the company achieved a turnover of €3.2M last year.

 

About Prim

Prim is a privately owned Spanish business group listed on the Madrid Stock Exchange since 1985. The Group is a reference in the hospital and orthopaedic supplies market, in physiotherapy, thalassotherapy, thermalism, spa, rehabilitation, geriatrics and technical aids. Its activity is divided into six divisions: Hospitals, Orthopaedics, Orthopaedic Clinics, Physiotherapy and Rehabilitation, Pharma and Spa.

It is the leading supplier of healthcare products and services in the Spanish market, with more than 22,000 references in its product portfolio. The Prim Group closed the last financial year with an increase in turnover of 11%, reaching €110.1M, with a net profit of €11.26M (compared to €10.7M in 2015) and a margin on sales of 10.24%. Its ebitda was €15M, 12.7% higher than in 2016, and its financial debt was also reduced by 24.4% last year, with a volume of €1.6M.

Prim acquires distributor Anota for €1.23m

Prim, a company dedicated to the supply of hospital and orthopaedic devices, has acquired the distribution company for pharmacies and orthopaedics Anota for €1.23m. The transaction will be supplemented by a variable portion that will be subject to the results of the acquired company between 2019 and 2021.

This operation reinforces the Prim Group's presence in this channel, allowing it to continue to make progress in its growth strategy within the healthcare sector, thanks to the complementary nature of the structures of the two companies in operational terms, as well as in terms of their distribution and sales network and their range of products.

Top M&A transactions in the Pharmaceutical sector in 2017

Lastest news

State of technology M&A in Spain | Analysis August 2025

El mes de agosto, tradicionalmente más pausado en cuanto a transacciones corporativas, ha sorprendido en 2025 con una intensa actividad en el ámbito tecnológico en España. Se registraron operaciones de gran calado en segmentos como marketplaces digitales,...

Baker Tilly advises BSG on its acquisition of Copermática

The advisors for the sale and purchase of technology companies at Baker Tilly Tech M&A have advised Business Software Group (BSG) on its recent acquisition of Copermática, a company specialising in management software for professional firms and consultancies. With...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42